Am J Epidemiol. 2023 Feb 24;192(3):367-376. doi: 10.1093/aje/kwac208.
Although racial/ethnic disparities in health-care access, treatment, and cancer outcomes are well documented, the impact of racial/ethnic discrimination on cancer survivorship is unclear. We examined associations between quality of life (QoL) and self-reported discrimination among 3,991 women with breast cancer recruited during 2006-2013 from the Pathways Study in the Kaiser Permanente Northern California integrated health-care system, using linear regression models. Overall, 31% of women reported experiencing racial/ethnic discrimination, with differences by race/ethnicity (82% among non-Hispanic Black women vs. 19% among non-Hispanic White women) and nativity (40% among foreign-born Hispanic women vs. 76% among US-born Asian-American women). Experiencing racial/ethnic discrimination was associated with lower QoL in fully adjusted models. The mean QoL score was 119.6 (95% confidence interval (CI): 102.0, 137.1) for women who did not report discrimination, 115.5 (95% CI: 98.0, 133.0) for those who reported some discrimination/less than the median level, and 110.2 (95% CI: 92.7, 127.7) for those who reported more discrimination/greater than or equal to the median level. Discrimination was associated with lower QoL among women who used passive coping strategies or lived in neighborhoods with high neighborhood socioeconomic status, neighborhoods with high levels of segregation, or non-ethnic enclaves. Among breast cancer survivors, clinically meaningful differences in QoL scores were associated with racial/ethnic discrimination. Additional studies are needed to understand potential pathways through which these social factors affect survivorship outcomes.
尽管医疗保健获取、治疗和癌症结果方面的种族/民族差异得到了充分记录,但种族/民族歧视对癌症生存的影响尚不清楚。我们使用线性回归模型,检查了 2006-2013 年期间在 Kaiser Permanente 北加州综合医疗保健系统的 Pathways 研究中招募的 3991 名乳腺癌女性中生活质量(QoL)和自我报告歧视之间的关联。总体而言,31%的女性报告经历过种族/民族歧视,不同种族/民族之间存在差异(非西班牙裔黑人女性中 82%,而非西班牙裔白人女性中 19%)和出生地(外国出生的西班牙裔女性中 40%,美国出生的亚裔女性中 76%)。在完全调整的模型中,经历种族/民族歧视与 QoL 降低相关。在没有报告歧视的女性中,QoL 评分平均为 119.6(95%置信区间(CI):102.0,137.1),报告有一些歧视/低于中位数水平的女性为 115.5(95% CI:98.0,133.0),报告有更多歧视/等于或大于中位数水平的女性为 110.2(95% CI:92.7,127.7)。在使用被动应对策略或居住在邻里社会经济地位高、隔离程度高、或非族裔飞地的社区的女性中,歧视与 QoL 降低相关。在乳腺癌幸存者中,QoL 评分的临床显著差异与种族/民族歧视相关。需要进一步研究以了解这些社会因素影响生存结果的潜在途径。